前立腺特異抗原（PSA）テストのグローバル市場：規模・現状・予測2019-2025

• 英文タイトル：Global Prostate-specific Antigen (PSA) Testing Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9NV18329 • 出版社/出版日：QYResearch / 2019年11月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、129ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

※当調査レポートでは、前立腺特異抗原（PSA）テストの世界市場について調査・分析し、前立腺特異抗原（PSA）テストの世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（CLIA法、ELISA法）、用途別（スクリーニング、治療後モニタリング、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の前立腺特異抗原（PSA）テスト市場動向 ・主要企業別マーケットシェア ・前立腺特異抗原（PSA）テストの種類別市場規模2014-2019 （CLIA法、ELISA法） ・前立腺特異抗原（PSA）テストの用途別市場規模2014-2019 （スクリーニング、治療後モニタリング、その他） ・前立腺特異抗原（PSA）テストの北米市場：主要企業・種類別/用途別市場規模 ・前立腺特異抗原（PSA）テストのヨーロッパ市場：主要企業・種類別/用途別市場規模 ・前立腺特異抗原（PSA）テストの中国市場：主要企業・種類別/用途別市場規模 ・前立腺特異抗原（PSA）テストの日本国内市場：主要企業・種類別/用途別市場規模 ・前立腺特異抗原（PSA）テストの東南アジア市場：主要企業・種類別/用途別市場規模 ・前立腺特異抗原（PSA）テストのインド市場：主要企業・種類別/用途別市場規模 ・前立腺特異抗原（PSA）テストの中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Abbott、Boston Scientific Corporation、Bayer AG、Siemens Healthcare、DiaSorin、Roche、Beckman Coulter、PerkinElmer、Tosoh、Ortho Clinical、Fujirebio、Mediwatch、BodiTech、Bristol-Myers Squibb Company、GE Healthcare、Endocare、Merck＆Co.、Medtronic、Sanofi-Aventis SA） ・前立腺特異抗原（PSA）テストの市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ...

Prostate-specific antigen (PSA) is a protein secreted only by epithelial prostate cells, and its elevation in serum is used to detect prostate cancer in men.Elevated PSA levels are associated with prostatitis, inflammation of the prostate or benign forms of prostatic hyperplasia, making it a valuable tumor marker for prostate cancer.The use of serology-based biomarkers for the diagnosis of prostate cancer has stimulated the need for prostate-specific antigen (PSA).In 2018, the global Prostate-specific Antigen (PSA) Testing market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Prostate-specific Antigen (PSA) Testing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Prostate-specific Antigen (PSA) Testing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Abbott
Boston Scientific Corporation
Bayer AG
Siemens Healthcare
DiaSorin
Roche
Beckman Coulter
PerkinElmer
Tosoh
Ortho Clinical
Fujirebio
Mediwatch
BodiTech
Bristol-Myers Squibb Company
GE Healthcare
Endocare
Merck＆Co.
Medtronic
Sanofi-Aventis SA

Market segment by Type, the product can be split into
CLIA Method
ELISA Method

Market segment by Application, split into
Screening
Post-treatment Monitoring
Other

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Prostate-specific Antigen (PSA) Testing status, future forecast, growth opportunity, key market and key players.
To present the Prostate-specific Antigen (PSA) Testing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Prostate-specific Antigen (PSA) Testing are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

---

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Prostate-specific Antigen (PSA) Testing Market Size Growth Rate by Type (2014-2025)
1.4.2 CLIA Method
1.4.3 ELISA Method
1.5 Market by Application
1.5.1 Global Prostate-specific Antigen (PSA) Testing Market Share by Application (2019-2025)
1.5.2 Screening
1.5.3 Post-treatment Monitoring
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Prostate-specific Antigen (PSA) Testing Market Size
2.2 Prostate-specific Antigen (PSA) Testing Growth Trends by Regions
2.2.1 Prostate-specific Antigen (PSA) Testing Market Size by Regions (2019-2025)
2.2.2 Prostate-specific Antigen (PSA) Testing Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Prostate-specific Antigen (PSA) Testing Market Size by by Players
3.1.1 Global Prostate-specific Antigen (PSA) Testing Revenue by by Players (2014-2019)
3.1.2 Global Prostate-specific Antigen (PSA) Testing Revenue Market Share by by Players (2014-2019)
3.1.3 Global Prostate-specific Antigen (PSA) Testing Market Concentration Ratio (CR5 and HHI)
3.2 Prostate-specific Antigen (PSA) Testing Key Players Head office and Area Served
3.3 Key Players Prostate-specific Antigen (PSA) Testing Product/Solution/Service
3.4 Date of Enter into Prostate-specific Antigen (PSA) Testing Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Prostate-specific Antigen (PSA) Testing Market Size by Type (2014-2019)
4.2 Global Prostate-specific Antigen (PSA) Testing Market Size by Application (2014-2019)

5 North America
5.1 North America Prostate-specific Antigen (PSA) Testing Market Size (2014-2019)
5.2 Prostate-specific Antigen (PSA) Testing Key Players in North America
5.3 North America Prostate-specific Antigen (PSA) Testing Market Size by Type
5.4 North America Prostate-specific Antigen (PSA) Testing Market Size by Application

6 Europe
6.1 Europe Prostate-specific Antigen (PSA) Testing Market Size (2014-2019)
6.2 Prostate-specific Antigen (PSA) Testing Key Players in Europe
6.3 Europe Prostate-specific Antigen (PSA) Testing Market Size by Type
6.4 Europe Prostate-specific Antigen (PSA) Testing Market Size by Application

7 China
7.1 China Prostate-specific Antigen (PSA) Testing Market Size (2014-2019)
7.2 Prostate-specific Antigen (PSA) Testing Key Players in China
7.3 China Prostate-specific Antigen (PSA) Testing Market Size by Type
7.4 China Prostate-specific Antigen (PSA) Testing Market Size by Application

8 Japan
8.1 Japan Prostate-specific Antigen (PSA) Testing Market Size (2014-2019)
8.2 Prostate-specific Antigen (PSA) Testing Key Players in Japan
8.3 Japan Prostate-specific Antigen (PSA) Testing Market Size by Type
8.4 Japan Prostate-specific Antigen (PSA) Testing Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Prostate-specific Antigen (PSA) Testing Market Size (2014-2019)
9.2 Prostate-specific Antigen (PSA) Testing Key Players in Southeast Asia
9.3 Southeast Asia Prostate-specific Antigen (PSA) Testing Market Size by Type
9.4 Southeast Asia Prostate-specific Antigen (PSA) Testing Market Size by Application

10 India
10.1 India Prostate-specific Antigen (PSA) Testing Market Size (2014-2019)
10.2 Prostate-specific Antigen (PSA) Testing Key Players in India
10.3 India Prostate-specific Antigen (PSA) Testing Market Size by Type
10.4 India Prostate-specific Antigen (PSA) Testing Market Size by Application

11 Central & South America
11.1 Central & South America Prostate-specific Antigen (PSA) Testing Market Size (2014-2019)
11.2 Prostate-specific Antigen (PSA) Testing Key Players in Central & South America
11.3 Central & South America Prostate-specific Antigen (PSA) Testing Market Size by Type
11.4 Central & South America Prostate-specific Antigen (PSA) Testing Market Size by Application

12 International Players Profiles
12.1 Abbott
12.1.1 Abbott Company Details
12.1.2 Company Description and Business Overview
12.1.3 Prostate-specific Antigen (PSA) Testing Introduction
12.1.4 Abbott Revenue in Prostate-specific Antigen (PSA) Testing Business (2014-2019))
12.1.5 Abbott Recent Development
12.2 Boston Scientific Corporation
12.2.1 Boston Scientific Corporation Company Details
12.2.2 Company Description and Business Overview
12.2.3 Prostate-specific Antigen (PSA) Testing Introduction
12.2.4 Boston Scientific Corporation Revenue in Prostate-specific Antigen (PSA) Testing Business (2014-2019)
12.2.5 Boston Scientific Corporation Recent Development
12.3 Bayer AG
12.3.1 Bayer AG Company Details
12.3.2 Company Description and Business Overview
12.3.3 Prostate-specific Antigen (PSA) Testing Introduction
12.3.4 Bayer AG Revenue in Prostate-specific Antigen (PSA) Testing Business (2014-2019)
12.3.5 Bayer AG Recent Development
12.4 Siemens Healthcare
12.4.1 Siemens Healthcare Company Details
12.4.2 Company Description and Business Overview
12.4.3 Prostate-specific Antigen (PSA) Testing Introduction
12.4.4 Siemens Healthcare Revenue in Prostate-specific Antigen (PSA) Testing Business (2014-2019)
12.4.5 Siemens Healthcare Recent Development
12.5 DiaSorin
12.5.1 DiaSorin Company Details
12.5.2 Company Description and Business Overview
12.5.3 Prostate-specific Antigen (PSA) Testing Introduction
12.5.4 DiaSorin Revenue in Prostate-specific Antigen (PSA) Testing Business (2014-2019)
12.5.5 DiaSorin Recent Development
12.6 Roche
12.6.1 Roche Company Details
12.6.2 Company Description and Business Overview
12.6.3 Prostate-specific Antigen (PSA) Testing Introduction
12.6.4 Roche Revenue in Prostate-specific Antigen (PSA) Testing Business (2014-2019)
12.6.5 Roche Recent Development
12.7 Beckman Coulter
12.7.1 Beckman Coulter Company Details
12.7.2 Company Description and Business Overview
12.7.3 Prostate-specific Antigen (PSA) Testing Introduction
12.7.4 Beckman Coulter Revenue in Prostate-specific Antigen (PSA) Testing Business (2014-2019)
12.7.5 Beckman Coulter Recent Development
12.8 PerkinElmer
12.8.1 PerkinElmer Company Details
12.8.2 Company Description and Business Overview
12.8.3 Prostate-specific Antigen (PSA) Testing Introduction
12.8.4 PerkinElmer Revenue in Prostate-specific Antigen (PSA) Testing Business (2014-2019)
12.8.5 PerkinElmer Recent Development
12.9 Tosoh
12.9.1 Tosoh Company Details
12.9.2 Company Description and Business Overview
12.9.3 Prostate-specific Antigen (PSA) Testing Introduction
12.9.4 Tosoh Revenue in Prostate-specific Antigen (PSA) Testing Business (2014-2019)
12.9.5 Tosoh Recent Development
12.10 Ortho Clinical
12.10.1 Ortho Clinical Company Details
12.10.2 Company Description and Business Overview
12.10.3 Prostate-specific Antigen (PSA) Testing Introduction
12.10.4 Ortho Clinical Revenue in Prostate-specific Antigen (PSA) Testing Business (2014-2019)
12.10.5 Ortho Clinical Recent Development
12.11 Fujirebio
12.12 Mediwatch
12.13 BodiTech
12.14 Bristol-Myers Squibb Company
12.15 GE Healthcare
12.16 Endocare
12.17 Merck＆Co.
12.18 Medtronic
12.19 Sanofi-Aventis SA

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Prostate-specific Antigen (PSA) Testing Key Market Segments
Table Key Players Prostate-specific Antigen (PSA) Testing Covered
Table Global Prostate-specific Antigen (PSA) Testing Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer CLIA Method Figures
Table Key Players of CLIA Method
Figuer ELISA Method Figures
Table Key Players of ELISA Method
Table Global Prostate-specific Antigen (PSA) Testing Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Prostate-specific Antigen (PSA) Testing Market Share by Application in 2018 & 2025
Figure Screening Case Studies
Figure Post-treatment Monitoring Case Studies
Figure Other Case Studies
Figure Prostate-specific Antigen (PSA) Testing Report Years Considered
Figure Global Prostate-specific Antigen (PSA) Testing Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Prostate-specific Antigen (PSA) Testing Market Size by Regions 2019-2025 (Million US$)
Table Global Prostate-specific Antigen (PSA) Testing Market Size by Regions 2019-2025 (Million US$)
Table Global Prostate-specific Antigen (PSA) Testing Market Share by Regions 2014-2019
Figure Global Prostate-specific Antigen (PSA) Testing Market Share by Regions 2014-2019
Figure Global Prostate-specific Antigen (PSA) Testing Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Prostate-specific Antigen (PSA) Testing Revenue by by Players (2014-2019) (Million US$)
Table Global Prostate-specific Antigen (PSA) Testing Market Share by by Players (2014-2019)
Figure Global Prostate-specific Antigen (PSA) Testing Market Share by by Players in 2018
Table Global Prostate-specific Antigen (PSA) Testing by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Prostate-specific Antigen (PSA) Testing Product/Solution/Service
Table Date of Enter into Prostate-specific Antigen (PSA) Testing Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Prostate-specific Antigen (PSA) Testing Market Size by Type (2014-2019) (Million US$)
Table Global Prostate-specific Antigen (PSA) Testing Market Size Share by Type (2014-2019)
Figure Global Prostate-specific Antigen (PSA) Testing Market Size Market Share by Type (2014-2019)
Table Global Prostate-specific Antigen (PSA) Testing Market Size by Application (2014-2019) (Million US$)
Table Global Prostate-specific Antigen (PSA) Testing Market Size Share by Application (2014-2019)
Figure Global Prostate-specific Antigen (PSA) Testing Market Size Market Share by Application (2014-2019)
Figure Global Prostate-specific Antigen (PSA) Testing Revenue Market Share by Application in 2018
Figure North America Prostate-specific Antigen (PSA) Testing Market Size 2014-2019 (Million US$)
Table North America Key Players Prostate-specific Antigen (PSA) Testing Revenue (2018-2019) (Million US$)
Table North America Key Players Prostate-specific Antigen (PSA) Testing Market Share (2018-2019)
Table North America Prostate-specific Antigen (PSA) Testing Market Size by Type 2014-2019 (Million US$)
Table North America Prostate-specific Antigen (PSA) Testing Market Share by Type 2014-2019
Table North America Prostate-specific Antigen (PSA) Testing Market Size by Application 2014-2019 (Million US$)
Table North America Prostate-specific Antigen (PSA) Testing Market Share by Application 2014-2019
Figure Europe Prostate-specific Antigen (PSA) Testing Market Size 2014-2019 (Million US$)
Table Europe Key Players Prostate-specific Antigen (PSA) Testing Revenue (2018-2019) (Million US$)
Table Europe Key Players Prostate-specific Antigen (PSA) Testing Market Share (2018-2019)
Table Europe Prostate-specific Antigen (PSA) Testing Market Size by Type 2014-2019 (Million US$)
Table Europe Prostate-specific Antigen (PSA) Testing Market Share by Type 2014-2019
Table Europe Prostate-specific Antigen (PSA) Testing Market Size by Application 2014-2019 (Million US$)
Table Europe Prostate-specific Antigen (PSA) Testing Market Share by Application 2014-2019
Figure China Prostate-specific Antigen (PSA) Testing Market Size 2014-2019 (Million US$)
Table China Key Players Prostate-specific Antigen (PSA) Testing Revenue (2018-2019) (Million US$)
Table China Key Players Prostate-specific Antigen (PSA) Testing Market Share (2018-2019)
Table China Prostate-specific Antigen (PSA) Testing Market Size by Type 2014-2019 (Million US$)
Table China Prostate-specific Antigen (PSA) Testing Market Share by Type 2014-2019
Table China Prostate-specific Antigen (PSA) Testing Market Size by Application 2014-2019 (Million US$)
Table China Prostate-specific Antigen (PSA) Testing Market Share by Application 2014-2019
Figure Japan Prostate-specific Antigen (PSA) Testing Market Size 2014-2019 (Million US$)
Table Japan Key Players Prostate-specific Antigen (PSA) Testing Revenue (2018-2019) (Million US$)
Table Japan Key Players Prostate-specific Antigen (PSA) Testing Market Share (2018-2019)
Table Japan Prostate-specific Antigen (PSA) Testing Market Size by Type 2014-2019 (Million US$)
Table Japan Prostate-specific Antigen (PSA) Testing Market Share by Type 2014-2019
Table Japan Prostate-specific Antigen (PSA) Testing Market Size by Application 2014-2019 (Million US$)
Table Japan Prostate-specific Antigen (PSA) Testing Market Share by Application 2014-2019
Figure Southeast Asia Prostate-specific Antigen (PSA) Testing Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Prostate-specific Antigen (PSA) Testing Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Prostate-specific Antigen (PSA) Testing Market Share (2018-2019)
Table Southeast Asia Prostate-specific Antigen (PSA) Testing Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Prostate-specific Antigen (PSA) Testing Market Share by Type 2014-2019
Table Southeast Asia Prostate-specific Antigen (PSA) Testing Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Prostate-specific Antigen (PSA) Testing Market Share by Application 2014-2019
Figure India Prostate-specific Antigen (PSA) Testing Market Size 2014-2019 (Million US$)
Table India Key Players Prostate-specific Antigen (PSA) Testing Revenue (2018-2019) (Million US$)
Table India Key Players Prostate-specific Antigen (PSA) Testing Market Share (2018-2019)
Table India Prostate-specific Antigen (PSA) Testing Market Size by Type 2014-2019 (Million US$)
Table India Prostate-specific Antigen (PSA) Testing Market Share by Type 2014-2019
Table India Prostate-specific Antigen (PSA) Testing Market Size by Application 2014-2019 (Million US$)
Table India Prostate-specific Antigen (PSA) Testing Market Share by Application 2014-2019
Figure Central & South America Prostate-specific Antigen (PSA) Testing Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Prostate-specific Antigen (PSA) Testing Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Prostate-specific Antigen (PSA) Testing Market Share (2018-2019)
Table Central & South America Prostate-specific Antigen (PSA) Testing Market Size by Type 2014-2019 (Million US$)
Table Central & South America Prostate-specific Antigen (PSA) Testing Market Share by Type 2014-2019
Table Central & South America Prostate-specific Antigen (PSA) Testing Market Size by Application 2014-2019 (Million US$)
Table Central & South America Prostate-specific Antigen (PSA) Testing Market Share by Application 2014-2019
Table Abbott Company Details
Table Abbott Revenue in Prostate-specific Antigen (PSA) Testing Business 2014-2019 (Million US$)
Figure Abbott Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2014-2019)
Table Abbott Recent Development
Table Boston Scientific Corporation Company Details
Table Boston Scientific Corporation Revenue in Prostate-specific Antigen (PSA) Testing Business 2014-2019 (Million US$)
Figure Boston Scientific Corporation Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2014-2019)
Table Boston Scientific Corporation Recent Development
Table Bayer AG Company Details
Table Bayer AG Revenue in Prostate-specific Antigen (PSA) Testing Business 2014-2019 (Million US$)
Figure Bayer AG Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2014-2019)
Table Bayer AG Recent Development
Table Siemens Healthcare Company Details
Table Siemens Healthcare Revenue in Prostate-specific Antigen (PSA) Testing Business 2014-2019 (Million US$)
Figure Siemens Healthcare Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2014-2019)
Table Siemens Healthcare Recent Development
Table DiaSorin Company Details
Table DiaSorin Revenue in Prostate-specific Antigen (PSA) Testing Business 2014-2019 (Million US$)
Figure DiaSorin Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2014-2019)
Table DiaSorin Recent Development
Table Roche Company Details
Table Roche Revenue in Prostate-specific Antigen (PSA) Testing Business 2014-2019 (Million US$)
Figure Roche Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2014-2019)
Table Roche Recent Development
Table Beckman Coulter Company Details
Table Beckman Coulter Revenue in Prostate-specific Antigen (PSA) Testing Business 2014-2019 (Million US$)
Figure Beckman Coulter Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2014-2019)
Table Beckman Coulter Recent Development
Table PerkinElmer Company Details
Table PerkinElmer Revenue in Prostate-specific Antigen (PSA) Testing Business 2014-2019 (Million US$)
Figure PerkinElmer Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2014-2019)
Table PerkinElmer Recent Development
Table Tosoh Company Details
Table Tosoh Revenue in Prostate-specific Antigen (PSA) Testing Business 2014-2019 (Million US$)
Figure Tosoh Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2014-2019)
Table Tosoh Recent Development
Table Ortho Clinical Company Details
Table Ortho Clinical Revenue in Prostate-specific Antigen (PSA) Testing Business 2014-2019 (Million US$)
Figure Ortho Clinical Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2014-2019)
Table Ortho Clinical Recent Development
Table Fujirebio Company Details
Table Mediwatch Company Details
Table BodiTech Company Details
Table Bristol-Myers Squibb Company Company Details
Table GE Healthcare Company Details
Table Endocare Company Details
Table Merck＆Co. Company Details
Table Medtronic Company Details
Table Sanofi-Aventis SA Company Details
Table Global Prostate-specific Antigen (PSA) Testing Market Size by Regions (Million US$) 2019-2025
Figure Global Prostate-specific Antigen (PSA) Testing Market Size Share by Regions (2019-2025)
Figure Global Prostate-specific Antigen (PSA) Testing Market Size Share by Regions in 2025
Figure North America Prostate-specific Antigen (PSA) Testing Market Size Forecast (2019-2025)(Million USD)
Figure Europe Prostate-specific Antigen (PSA) Testing Market Size Forecast (2019-2025)(Million USD)
Figure China Prostate-specific Antigen (PSA) Testing Market Size Forecast (2019-2025)(Million USD)
Figure Japan Prostate-specific Antigen (PSA) Testing Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Prostate-specific Antigen (PSA) Testing Market Size Forecast (2019-2025)(Million USD)
Figure India Prostate-specific Antigen (PSA) Testing Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Prostate-specific Antigen (PSA) Testing Market Size Forecast (2019-2025)(Million USD)
Table Global Prostate-specific Antigen (PSA) Testing Market Size by Product (2019-2025) (Million US$)
Figure Global Prostate-specific Antigen (PSA) Testing Market Size by Product (2019-2025)
Figure Global Prostate-specific Antigen (PSA) Testing Market Size by Product in 2025
Table Global Prostate-specific Antigen (PSA) Testing Market Size by Application (2019-2025) (Million US$)
Figure Global Prostate-specific Antigen (PSA) Testing Market Size by Application (2019-2025)
Figure Global Prostate-specific Antigen (PSA) Testing Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

---